Sofwave Medical Ltd
SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin rejuvenation and firming treatments in Israel and internationally. The company offers an ultrasound technology, which induces coagulation and subsequent revitalization under the SUPERB brand name; and non-invasive muscle toning technology under the Pure Impact brand… Read more
Sofwave Medical Ltd (SOFW) - Total Liabilities
Latest total liabilities as of September 2025: ILA18.95 Million ILA
Based on the latest financial reports, Sofwave Medical Ltd (SOFW) has total liabilities worth ILA18.95 Million ILA as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Sofwave Medical Ltd - Total Liabilities Trend (2018–2024)
This chart illustrates how Sofwave Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Sofwave Medical Ltd Competitors by Total Liabilities
The table below lists competitors of Sofwave Medical Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Afrimat
JSE:AFT
|
South Africa | ZAC4.82 Billion |
|
K2 Asset Management Holdings Ltd
AU:KAM
|
Australia | AU$2.93 Million |
|
Zhengye Biotechnology Holding Limited Ordinary Shares
NASDAQ:ZYBT
|
USA | $140.71 Million |
|
BIG Industries Bhd
KLSE:7005
|
Malaysia | RM17.55 Million |
|
P3 Health Partners Inc
NASDAQ:PIII
|
USA | $664.64 Million |
|
Indah Prakasa Sentosa PT Tbk
JK:INPS
|
Indonesia | Rp283.96 Billion |
|
Restaurant Brands New Zealand Limited
PINK:RTBRF
|
USA | $1.09 Billion |
|
JBDI Holdings Limited Ordinary Shares
NASDAQ:JBDI
|
USA | $1.99 Million |
Liability Composition Analysis (2018–2024)
This chart breaks down Sofwave Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.68 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Sofwave Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Sofwave Medical Ltd (2018–2024)
The table below shows the annual total liabilities of Sofwave Medical Ltd from 2018 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ILA18.50 Million | +7.62% |
| 2023-12-31 | ILA17.19 Million | +25.15% |
| 2022-12-31 | ILA13.74 Million | -2.34% |
| 2021-12-31 | ILA14.07 Million | +327.96% |
| 2020-12-31 | ILA3.29 Million | +55.41% |
| 2019-12-31 | ILA2.12 Million | +73.79% |
| 2018-12-31 | ILA1.22 Million | -- |